Launch of new antiviral against COVID-19
A new drug developed by the Defense Research and Development Organization (DRDO) in association with Dr. Reddy’s Laboratories Ltd has been launched following approval for emergency use in the treatmen
2-deoxy-d-glucose (2-DG) – Launch of new antiviral against COVID-19.
A new drug developed by the Defense Research and Development Organization (DRDO) in association with Dr. Reddy’s Laboratories Ltd has been launched following approval for emergency use in the treatment of Covid-19 patients by the Drug Control General of India (DCGI).
This drug is only available in India and there is no data from any other country regarding its use in COVID-19 patients.
Comments
Post a Comment